Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7828]
Articles [63]
Editorials [9]
Conferences [210]
elearning [49]
New agent, eribulin, derived from marine sponge, increases survival among women...
Prof Christopher Twelves - Leeds Institute of Molecular Medicine and St...
New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer ( Prof Christopher Twelves - Leeds Institute of Molecular Medicine and St. James's Institute of Oncology, Leeds, UK )
11 Jun 2010
ALK inhibitor shows high response rate in patients with advanced NSCLC...
Prof Yung-Jue Bang - Seoul National University College of Medicine, Seoul, Korea
ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration ( Prof Yung-Jue Bang - Seoul National University College of Medicine, Seoul, Korea )
11 Jun 2010
The role of genetic mutations in lung cancer
Prof Fred Hirsch - University of Colorado, Denver
The role of genetic mutations in lung cancer ( Prof Fred Hirsch - University of Colorado, Denver )
8 Jun 2010
The use of targeted radiotherapy to treat lung cancer
Prof Paul Van Houtte - Institut Jules Bordet, Brussels
The use of targeted radiotherapy to treat lung cancer ( Prof Paul Van Houtte - Institut Jules Bordet, Brussels )
7 Jun 2010
The future of lung cancer treatment
Prof Pieter Postmus - Vrije Universiteit Medical Centre, Amsterdam
The future of lung cancer treatment ( Prof Pieter Postmus - Vrije Universiteit Medical Centre, Amsterdam )
7 Jun 2010
Lung cancer treatment: new drugs and possibilities
Prof Peter Harper - Kings College, London
Lung cancer treatment: new drugs and possibilities ( Prof Peter Harper - Kings College, London )
7 Jun 2010
Personalised treatment for lung cancer
Prof Paul Bunn - University of Colorado, Denver
Personalised treatment for lung cancer ( Prof Paul Bunn - University of Colorado, Denver )
7 Jun 2010
Ways to predict efficacy of anthracyclines
Dr Christine Desmedt - Jules Bordet Institute, Brussels
Ways to predict efficacy of anthracyclines ( Dr Christine Desmedt - Jules Bordet Institute, Brussels )
22 Apr 2010
Barriers for patient participation in clinical trials
Ingrid Kossler - Swedish Breast Cancer Association
Barriers for patient participation in clinical trials ( Ingrid Kossler - Swedish Breast Cancer Association )
22 Apr 2010
Progress made by the Dutch Colorectal Cancer Group and key issues emerging from...
Prof Cornelis Punt - Radboud University and Nijmegen Medical Centre, the...
Progress made by the Dutch Colorectal Cancer Group and key issues emerging from the 2010 EMCCC conference ( Prof Cornelis Punt - Radboud University and Nijmegen Medical Centre, the Netherlands )
19 Apr 2010
Roundup of the 7th European Breast Cancer Conference, Barcelona
Prof Gordon McVie - European Institute of Oncology, Milan
Roundup of the 7th European Breast Cancer Conference, Barcelona ( Prof Gordon McVie - European Institute of Oncology, Milan )
15 Apr 2010
HER 2: Interpretation of ICH and FISH Assays - Molecular Pathology Education...
Professor Giuseppe Viale - European Institute of Oncology
HER 2: Interpretation of ICH and FISH Assays - Molecular Pathology Education Module 3 ( Professor Giuseppe Viale - European Institute of Oncology )
17 Feb 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation